 | • レポートコード：MRC2Q12-18832 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、アムホテリシンB注射のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 アムホテリシンB注射のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 アムホテリシンB注射の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 アムホテリシンB注射のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのアムホテリシンB注射の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のアムホテリシンB注射の売上および2028年までの予測に焦点を当てています。 アムホテリシンB注射のグローバル主要企業には、Swiss Parenterals、Aspen Pharmacare、Health Biotech、Abbott Laboratories、Abraxis、Astellas Pharma、Bluepharma、Bristol Myers Squibb、Cheplapharm Arzneimittel、Clinigen Group、Flagship Biotech、Gilead Sciences、Ind Swift Laboratories、Kaliberr Labs、Kwality Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 アムホテリシンB注射市場は、タイプとアプリケーションによって区分されます。世界のアムホテリシンB注射市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 5Mg/バイアル、50Mg/バイアル、100Mg/バイアル 【アプリケーション別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - アムホテリシンB注射製品概要 - タイプ別市場（5Mg/バイアル、50Mg/バイアル、100Mg/バイアル） - アプリケーション別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のアムホテリシンB注射販売量予測2017-2028 - 世界のアムホテリシンB注射売上予測2017-2028 - アムホテリシンB注射の地域別販売量 - アムホテリシンB注射の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別アムホテリシンB注射販売量 - 主要メーカー別アムホテリシンB注射売上 - 主要メーカー別アムホテリシンB注射価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（5Mg/バイアル、50Mg/バイアル、100Mg/バイアル） - アムホテリシンB注射のタイプ別販売量 - アムホテリシンB注射のタイプ別売上 - アムホテリシンB注射のタイプ別価格 ・アプリケーション別市場規模（病院、診療所、その他） - アムホテリシンB注射のアプリケーション別販売量 - アムホテリシンB注射のアプリケーション別売上 - アムホテリシンB注射のアプリケーション別価格 ・北米市場 - 北米のアムホテリシンB注射市場規模（タイプ別、アプリケーション別） - 主要国別のアムホテリシンB注射市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのアムホテリシンB注射市場規模（タイプ別、アプリケーション別） - 主要国別のアムホテリシンB注射市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のアムホテリシンB注射市場規模（タイプ別、アプリケーション別） - 主要国別のアムホテリシンB注射市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のアムホテリシンB注射市場規模（タイプ別、アプリケーション別） - 主要国別のアムホテリシンB注射市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのアムホテリシンB注射市場規模（タイプ別、アプリケーション別） - 主要国別のアムホテリシンB注射市場規模（トルコ、サウジアラビア） ・企業情報 Swiss Parenterals、Aspen Pharmacare、Health Biotech、Abbott Laboratories、Abraxis、Astellas Pharma、Bluepharma、Bristol Myers Squibb、Cheplapharm Arzneimittel、Clinigen Group、Flagship Biotech、Gilead Sciences、Ind Swift Laboratories、Kaliberr Labs、Kwality Pharmaceuticals ・産業チェーン及び販売チャネル分析 - アムホテリシンB注射の産業チェーン分析 - アムホテリシンB注射の原材料 - アムホテリシンB注射の生産プロセス - アムホテリシンB注射の販売及びマーケティング - アムホテリシンB注射の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - アムホテリシンB注射の産業動向 - アムホテリシンB注射のマーケットドライバー - アムホテリシンB注射の課題 - アムホテリシンB注射の阻害要因 ・主な調査結果 |
Abelcet is a prescription medicine used to treat the symptoms of Systemic Fungal Infection
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Amphotericin B Injection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Amphotericin B Injection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Amphotericin B Injection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Amphotericin B Injection include Swiss Parenterals, Aspen Pharmacare, Health Biotech, Abbott Laboratories, Abraxis, Astellas Pharma, Bluepharma, Bristol Myers Squibb and Cheplapharm Arzneimittel, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Amphotericin B Injection manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Amphotericin B Injection market. Further, it explains the major drivers and regional dynamics of the global Amphotericin B Injection market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Swiss Parenterals
Aspen Pharmacare
Health Biotech
Abbott Laboratories
Abraxis
Astellas Pharma
Bluepharma
Bristol Myers Squibb
Cheplapharm Arzneimittel
Clinigen Group
Flagship Biotech
Gilead Sciences
Ind Swift Laboratories
Kaliberr Labs
Kwality Pharmaceuticals
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by dosage strength and by application segments based on sales, price, and value for the period 2017-2028.
Amphotericin B Injection Segment by Dosage Strength
5Mg/Vial
50Mg/Vial
100Mg/Vial
Amphotericin B Injection Segment by Application
Hospital
Clinic
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Amphotericin B Injection market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Amphotericin B Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Amphotericin B Injection, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Amphotericin B Injection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Amphotericin B Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Amphotericin B Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Amphotericin B Injection sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Swiss Parenterals, Aspen Pharmacare, Health Biotech, Abbott Laboratories, Abraxis, Astellas Pharma, Bluepharma, Bristol Myers Squibb and Cheplapharm Arzneimittel, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Amphotericin B Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Amphotericin B Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by dosage strength, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amphotericin B Injection sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Amphotericin B Injection Product Introduction
1.2 Market by Dosage Strength
1.2.1 Global Amphotericin B Injection Market Size Growth Rate by Dosage Strength, 2017 VS 2021 VS 2028
1.2.2 5Mg/Vial
1.2.3 50Mg/Vial
1.2.4 100Mg/Vial
1.3 Market by Application
1.3.1 Global Amphotericin B Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Amphotericin B Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Amphotericin B Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Amphotericin B Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Amphotericin B Injection Sales by Region
2.4.1 Global Amphotericin B Injection Sales by Region (2017-2022)
2.4.2 Global Sales Amphotericin B Injection by Region (2023-2028)
2.5 Global Amphotericin B Injection Revenue by Region
2.5.1 Global Amphotericin B Injection Revenue by Region (2017-2022)
2.5.2 Global Amphotericin B Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Amphotericin B Injection Sales by Manufacturers
3.1.1 Global Top Amphotericin B Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Amphotericin B Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Amphotericin B Injection in 2021
3.2 Global Amphotericin B Injection Revenue by Manufacturers
3.2.1 Global Amphotericin B Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Amphotericin B Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Amphotericin B Injection Revenue in 2021
3.3 Global Amphotericin B Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Amphotericin B Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Amphotericin B Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Dosage Strength
4.1 Global Amphotericin B Injection Sales by Dosage Strength
4.1.1 Global Amphotericin B Injection Historical Sales by Dosage Strength (2017-2022)
4.1.2 Global Amphotericin B Injection Forecasted Sales by Dosage Strength (2023-2028)
4.1.3 Global Amphotericin B Injection Sales Market Share by Dosage Strength (2017-2028)
4.2 Global Amphotericin B Injection Revenue by Dosage Strength
4.2.1 Global Amphotericin B Injection Historical Revenue by Dosage Strength (2017-2022)
4.2.2 Global Amphotericin B Injection Forecasted Revenue by Dosage Strength (2023-2028)
4.2.3 Global Amphotericin B Injection Revenue Market Share by Dosage Strength (2017-2028)
4.3 Global Amphotericin B Injection Price by Dosage Strength
4.3.1 Global Amphotericin B Injection Price by Dosage Strength (2017-2022)
4.3.2 Global Amphotericin B Injection Price Forecast by Dosage Strength (2023-2028)
5 Market Size by Application
5.1 Global Amphotericin B Injection Sales by Application
5.1.1 Global Amphotericin B Injection Historical Sales by Application (2017-2022)
5.1.2 Global Amphotericin B Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Amphotericin B Injection Sales Market Share by Application (2017-2028)
5.2 Global Amphotericin B Injection Revenue by Application
5.2.1 Global Amphotericin B Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Amphotericin B Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Amphotericin B Injection Revenue Market Share by Application (2017-2028)
5.3 Global Amphotericin B Injection Price by Application
5.3.1 Global Amphotericin B Injection Price by Application (2017-2022)
5.3.2 Global Amphotericin B Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Amphotericin B Injection Market Size by Dosage Strength
6.1.1 North America Amphotericin B Injection Sales by Dosage Strength (2017-2028)
6.1.2 North America Amphotericin B Injection Revenue by Dosage Strength (2017-2028)
6.2 North America Amphotericin B Injection Market Size by Application
6.2.1 North America Amphotericin B Injection Sales by Application (2017-2028)
6.2.2 North America Amphotericin B Injection Revenue by Application (2017-2028)
6.3 North America Amphotericin B Injection Market Size by Country
6.3.1 North America Amphotericin B Injection Sales by Country (2017-2028)
6.3.2 North America Amphotericin B Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Amphotericin B Injection Market Size by Dosage Strength
7.1.1 Europe Amphotericin B Injection Sales by Dosage Strength (2017-2028)
7.1.2 Europe Amphotericin B Injection Revenue by Dosage Strength (2017-2028)
7.2 Europe Amphotericin B Injection Market Size by Application
7.2.1 Europe Amphotericin B Injection Sales by Application (2017-2028)
7.2.2 Europe Amphotericin B Injection Revenue by Application (2017-2028)
7.3 Europe Amphotericin B Injection Market Size by Country
7.3.1 Europe Amphotericin B Injection Sales by Country (2017-2028)
7.3.2 Europe Amphotericin B Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Amphotericin B Injection Market Size by Dosage Strength
8.1.1 Asia Pacific Amphotericin B Injection Sales by Dosage Strength (2017-2028)
8.1.2 Asia Pacific Amphotericin B Injection Revenue by Dosage Strength (2017-2028)
8.2 Asia Pacific Amphotericin B Injection Market Size by Application
8.2.1 Asia Pacific Amphotericin B Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Amphotericin B Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Amphotericin B Injection Market Size by Region
8.3.1 Asia Pacific Amphotericin B Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Amphotericin B Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Amphotericin B Injection Market Size by Dosage Strength
9.1.1 Latin America Amphotericin B Injection Sales by Dosage Strength (2017-2028)
9.1.2 Latin America Amphotericin B Injection Revenue by Dosage Strength (2017-2028)
9.2 Latin America Amphotericin B Injection Market Size by Application
9.2.1 Latin America Amphotericin B Injection Sales by Application (2017-2028)
9.2.2 Latin America Amphotericin B Injection Revenue by Application (2017-2028)
9.3 Latin America Amphotericin B Injection Market Size by Country
9.3.1 Latin America Amphotericin B Injection Sales by Country (2017-2028)
9.3.2 Latin America Amphotericin B Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Amphotericin B Injection Market Size by Dosage Strength
10.1.1 Middle East and Africa Amphotericin B Injection Sales by Dosage Strength (2017-2028)
10.1.2 Middle East and Africa Amphotericin B Injection Revenue by Dosage Strength (2017-2028)
10.2 Middle East and Africa Amphotericin B Injection Market Size by Application
10.2.1 Middle East and Africa Amphotericin B Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Amphotericin B Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Amphotericin B Injection Market Size by Country
10.3.1 Middle East and Africa Amphotericin B Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Amphotericin B Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Swiss Parenterals
11.1.1 Swiss Parenterals Corporation Information
11.1.2 Swiss Parenterals Overview
11.1.3 Swiss Parenterals Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Swiss Parenterals Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Swiss Parenterals Recent Developments
11.2 Aspen Pharmacare
11.2.1 Aspen Pharmacare Corporation Information
11.2.2 Aspen Pharmacare Overview
11.2.3 Aspen Pharmacare Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Aspen Pharmacare Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Aspen Pharmacare Recent Developments
11.3 Health Biotech
11.3.1 Health Biotech Corporation Information
11.3.2 Health Biotech Overview
11.3.3 Health Biotech Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Health Biotech Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Health Biotech Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Corporation Information
11.4.2 Abbott Laboratories Overview
11.4.3 Abbott Laboratories Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Abbott Laboratories Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abbott Laboratories Recent Developments
11.5 Abraxis
11.5.1 Abraxis Corporation Information
11.5.2 Abraxis Overview
11.5.3 Abraxis Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Abraxis Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abraxis Recent Developments
11.6 Astellas Pharma
11.6.1 Astellas Pharma Corporation Information
11.6.2 Astellas Pharma Overview
11.6.3 Astellas Pharma Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Astellas Pharma Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Astellas Pharma Recent Developments
11.7 Bluepharma
11.7.1 Bluepharma Corporation Information
11.7.2 Bluepharma Overview
11.7.3 Bluepharma Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bluepharma Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bluepharma Recent Developments
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Corporation Information
11.8.2 Bristol Myers Squibb Overview
11.8.3 Bristol Myers Squibb Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bristol Myers Squibb Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol Myers Squibb Recent Developments
11.9 Cheplapharm Arzneimittel
11.9.1 Cheplapharm Arzneimittel Corporation Information
11.9.2 Cheplapharm Arzneimittel Overview
11.9.3 Cheplapharm Arzneimittel Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Cheplapharm Arzneimittel Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cheplapharm Arzneimittel Recent Developments
11.10 Clinigen Group
11.10.1 Clinigen Group Corporation Information
11.10.2 Clinigen Group Overview
11.10.3 Clinigen Group Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Clinigen Group Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Clinigen Group Recent Developments
11.11 Flagship Biotech
11.11.1 Flagship Biotech Corporation Information
11.11.2 Flagship Biotech Overview
11.11.3 Flagship Biotech Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Flagship Biotech Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Flagship Biotech Recent Developments
11.12 Gilead Sciences
11.12.1 Gilead Sciences Corporation Information
11.12.2 Gilead Sciences Overview
11.12.3 Gilead Sciences Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Gilead Sciences Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Gilead Sciences Recent Developments
11.13 Ind Swift Laboratories
11.13.1 Ind Swift Laboratories Corporation Information
11.13.2 Ind Swift Laboratories Overview
11.13.3 Ind Swift Laboratories Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Ind Swift Laboratories Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ind Swift Laboratories Recent Developments
11.14 Kaliberr Labs
11.14.1 Kaliberr Labs Corporation Information
11.14.2 Kaliberr Labs Overview
11.14.3 Kaliberr Labs Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Kaliberr Labs Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Kaliberr Labs Recent Developments
11.15 Kwality Pharmaceuticals
11.15.1 Kwality Pharmaceuticals Corporation Information
11.15.2 Kwality Pharmaceuticals Overview
11.15.3 Kwality Pharmaceuticals Amphotericin B Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Kwality Pharmaceuticals Amphotericin B Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Kwality Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Amphotericin B Injection Industry Chain Analysis
12.2 Amphotericin B Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Amphotericin B Injection Production Mode & Process
12.4 Amphotericin B Injection Sales and Marketing
12.4.1 Amphotericin B Injection Sales Channels
12.4.2 Amphotericin B Injection Distributors
12.5 Amphotericin B Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Amphotericin B Injection Industry Trends
13.2 Amphotericin B Injection Market Drivers
13.3 Amphotericin B Injection Market Challenges
13.4 Amphotericin B Injection Market Restraints
14 Key Findings in The Global Amphotericin B Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer